These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 33787221)

  • 1. A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells.
    Mellott DM; Tseng CT; Drelich A; Fajtová P; Chenna BC; Kostomiris DH; Hsu J; Zhu J; Taylor ZW; Kocurek KI; Tat V; Katzfuss A; Li L; Giardini MA; Skinner D; Hirata K; Yoon MC; Beck S; Carlin AF; Clark AE; Beretta L; Maneval D; Hook V; Frueh F; Hurst BL; Wang H; Raushel FM; O'Donoghue AJ; de Siqueira-Neto JL; Meek TD; McKerrow JH
    ACS Chem Biol; 2021 Apr; 16(4):642-650. PubMed ID: 33787221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells.
    Mellott DM; Tseng CT; Drelich A; Fajtová P; Chenna BC; Kostomiris DH; Hsu J; Zhu J; Taylor ZW; Tat V; Katzfuss A; Li L; Giardini MA; Skinner D; Hirata K; Beck S; Carlin AF; Clark AE; Beretta L; Maneval D; Frueh F; Hurst BL; Wang H; Kocurek KI; Raushel FM; O'Donoghue AJ; de Siqueira-Neto JL; Meek TD; McKerrow JH
    bioRxiv; 2020 Oct; ():. PubMed ID: 33140046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L.
    Ashhurst AS; Tang AH; Fajtová P; Yoon MC; Aggarwal A; Bedding MJ; Stoye A; Beretta L; Pwee D; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng CT; Larance M; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ
    J Med Chem; 2022 Feb; 65(4):2956-2970. PubMed ID: 34730959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent small molecule inhibitors of SARS-CoV-2 entry.
    Mediouni S; Mou H; Otsuka Y; Jablonski JA; Adcock RS; Batra L; Chung DH; Rood C; de Vera IMS; Rahaim R; Ullah S; Yu X; Getmanenko YA; Kennedy NM; Wang C; Nguyen TT; Hull M; Chen E; Bannister TD; Baillargeon P; Scampavia L; Farzan M; Valente ST; Spicer TP
    SLAS Discov; 2022 Jan; 27(1):8-19. PubMed ID: 35058179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors*.
    Yang KS; Ma XR; Ma Y; Alugubelli YR; Scott DA; Vatansever EC; Drelich AK; Sankaran B; Geng ZZ; Blankenship LR; Ward HE; Sheng YJ; Hsu JC; Kratch KC; Zhao B; Hayatshahi HS; Liu J; Li P; Fierke CA; Tseng CK; Xu S; Liu WR
    ChemMedChem; 2021 Mar; 16(6):942-948. PubMed ID: 33283984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro.
    Raghavan PR
    Biomed Res Int; 2022; 2022():1558860. PubMed ID: 35039793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L.
    Deng W; Hu X; Tian X; Zhang Y; Shang W; Zhang L; Shang L
    J Med Chem; 2024 Oct; 67(19):17124-17143. PubMed ID: 39292661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors.
    Falke S; Lieske J; Herrmann A; Loboda J; Karničar K; Günther S; Reinke PYA; Ewert W; Usenik A; Lindič N; Sekirnik A; Dretnik K; Tsuge H; Turk V; Chapman HN; Hinrichs W; Ebert G; Turk D; Meents A
    J Med Chem; 2024 May; 67(9):7048-7067. PubMed ID: 38630165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual inhibitor of PIP5K1C and PIKfyve prevents SARS-CoV-2 entry into cells.
    Seo Y; Jang Y; Lee SG; Rhlee JH; Kong S; Vo TTH; Kim MH; Lee MK; Kim B; Hong SY; Kim M; Lee JY; Myung K
    Exp Mol Med; 2024 Aug; 56(8):1736-1749. PubMed ID: 39085352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
    Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
    Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
    Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L.
    Ma XR; Alugubelli YR; Ma Y; Vatansever EC; Scott DA; Qiao Y; Yu G; Xu S; Liu WR
    ChemMedChem; 2022 Jan; 17(1):e202100456. PubMed ID: 34242492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors targeting coronavirus and filovirus entry.
    Zhou Y; Vedantham P; Lu K; Agudelo J; Carrion R; Nunneley JW; Barnard D; Pöhlmann S; McKerrow JH; Renslo AR; Simmons G
    Antiviral Res; 2015 Apr; 116():76-84. PubMed ID: 25666761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.
    Zhao MM; Yang WL; Yang FY; Zhang L; Huang WJ; Hou W; Fan CF; Jin RH; Feng YM; Wang YC; Yang JK
    Signal Transduct Target Ther; 2021 Mar; 6(1):134. PubMed ID: 33774649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    Begum F; Srivastava AK; Tripathi PP; Ray U
    J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
    Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
    ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
    Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.